Compare WVE & VSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | VSH |
|---|---|---|
| Founded | 2012 | 1962 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2015 | 1994 |
| Metric | WVE | VSH |
|---|---|---|
| Price | $7.07 | $34.88 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 16 | 2 |
| Target Price | ★ $29.81 | $18.00 |
| AVG Volume (30 Days) | ★ 3.9M | 3.3M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.44% |
| EPS Growth | N/A | ★ 69.57 |
| EPS | N/A | ★ N/A |
| Revenue | $3,704,000.00 | ★ $3,069,048,000.00 |
| Revenue This Year | N/A | $12.58 |
| Revenue Next Year | $85.67 | $6.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 149.43 | 4.48 |
| 52 Week Low | $5.02 | $11.77 |
| 52 Week High | $21.73 | $34.85 |
| Indicator | WVE | VSH |
|---|---|---|
| Relative Strength Index (RSI) | 39.03 | 82.58 |
| Support Level | $6.81 | $14.71 |
| Resistance Level | $7.67 | N/A |
| Average True Range (ATR) | 0.36 | 1.32 |
| MACD | 0.15 | 0.46 |
| Stochastic Oscillator | 28.00 | 93.73 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.